HARVARD BIOSCIENCE, INC. Increase (Decrease) in Other Current Liabilities
HARVARD BIOSCIENCE, INC. (HBIO) reported Increase (Decrease) in Other Current Liabilities of -$181.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2020-11-06
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for the quarter ending 2020-09-30 was -$513.00K, a 133.08% decline year-over-year.
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for the quarter ending 2020-06-30 was -$1.08M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for the quarter ending 2020-03-31 was $1.41M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for the quarter ending 2019-12-31 was -$1.44M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for fiscal 2019 was -$1.26M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in other current liabilities for fiscal 2018 was -$3.15M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$513.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.59M derived: sum of 2 quarters · filed 2020-11-06 | -$181.00K 10-Q · filed 2020-11-06 | -$1.62M derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $332.00K 10-Q · filed 2020-08-10 | -$1.10M derived: sum of 3 quarters · filed 2020-08-10 | $447.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-03-31 | $1.41M 10-Q · filed 2020-05-08 | -$25.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.53M derived: sum of 3 quarters · filed 2020-11-06 | $231.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $115.00K derived: sum of 2 quarters · filed 2020-11-06 | -$1.18M derived: sum of 3 quarters · filed 2020-11-06 | -$1.26M 10-K · filed 2020-03-16 |
| 2019-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $256.00K derived: sum of 2 quarters · filed 2020-11-06 | $180.00K 10-Q · filed 2020-11-06 | -$1.00M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.37M 10-Q · filed 2020-08-10 | -$2.55M derived: sum of 3 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$76.00K 10-Q · filed 2020-05-08 | -$1.26M derived: sum of 2 quarters · filed 2020-05-08 | ||
| 2018-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$3.15M 10-K · filed 2020-03-16 | ||
| 2018-09-30 | -$1.97M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |